Demand for mortality bonds offers chance to de-risk

Insurers underusing ILS as a way to manage exposures, say experts


Investors have shown an increased willingness to invest in sub-investment grade mortality bonds over the past few years and that trend is accelerating. This presents an opportunity for insurers to further de-risk balance sheets as Solvency II becomes business as usual, removing more underwriting risk for a lower price than ever before. But is it realistic to expect a glut of first-time issuers of extreme mortality bonds in a market that has been dominated by only a few big names?

Those few big

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: